|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.55 TWD | +1.25% |
|
+13.36% | -31.57% |
| 06-19 | Tanvex BioPharma, Inc. Appoints Val Chen as Corporate Governance Officer, Effective July 1, 2024 | CI |
| 06-19 | Tanvex BioPharma, Inc. Announces Change of Audit Committee Members | CI |
Tanvex BioPharma, Inc. announced the change of audit committee members. Name of the previous position holder: Chang, Chun-Yen. Resume of the previous position holder: Chang, Chun-Yen/Independent Director.
Name of the new position holder: Chang, Chi-feng; Hsieh, Shang-Hsien. Resume of the new position holder: Chang, Chi-feng/StemBios Technologies, Inc. Director; Hsieh, Shang-Hsien/Professor, Department of Civil Engineering, NTU. Effective date of the new member: June 19, 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.57% | 221M | |
| +16.52% | 122B | |
| +19.91% | 115B | |
| +21.22% | 26.64B | |
| -23.54% | 19.91B | |
| -17.47% | 16.32B | |
| -45.95% | 15.52B | |
| -18.61% | 15.49B | |
| +62.12% | 14.83B | |
| +2.58% | 13.67B |
TANVEX BIOPHARMA, INC. 
